Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.41CAD
17 May 2019
Change (% chg)

$-0.05 (-1.45%)
Prev Close
$3.46
Open
$3.51
Day's High
$3.53
Day's Low
$3.40
Volume
94,061
Avg. Vol
81,930
52-wk High
$4.94
52-wk Low
$1.11

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $682.93
Shares Outstanding(Mil.): 200.30
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -0.79 -- --
ROI: -- 7.41 11.59
ROE: -- 7.88 16.33

Earnings vs. Estimates